Former Investor Criticizes Moose Jaw Scientist Claims

A former investor has publicly expressed deep disappointment and concern over the latest claims made by Dayan Goodenowe, a controversial scientist based in Moose Jaw, Saskatchewan. The criticism comes as Goodenowe continues to promote new developments related to his health business and treatment programs.

The investor, Peter Blaney, who previously invested millions into Goodenowe’s earlier company, said his past experiences have led him to question the scientist’s credibility. Blaney described Goodenowe as someone who operates “in his own reality,” adding that many of the claims made over the years have not been supported by reliable results.

Goodenowe recently announced plans to build a drug manufacturing facility and clinical trials centre in Moose Jaw. He also claimed that his supplement, ProdromeNeuro, could potentially become an approved treatment for Alzheimer’s disease in the future. According to him, the product may go through regulatory approval processes in the coming years, with hopes of achieving major medical breakthroughs.

However, Blaney strongly disagrees with these claims. He said that during his time as an investor in Goodenowe’s previous company, Phenomenome Discoveries Inc., he witnessed repeated promises that were never fulfilled. He also revealed that he lost approximately $12 million through that investment, calling it one of the biggest mistakes of his career.

Concerns around Goodenowe are not limited to investor criticism. Earlier, the U.S. Food and Drug Administration issued a warning related to a study conducted by him, stating that proper approvals were not obtained before involving patients. This raised questions about both the safety of participants and the reliability of the research data.

In addition, several patients and families who participated in his health programs have claimed that they did not see the promised improvements. Some even reported that conditions continued to worsen despite following the treatment plans. Medical experts and organizations have also stated that there is currently no proven cure for diseases like ALS and Alzheimer’s, further challenging Goodenowe’s claims.

Legal disputes and investigations have also followed his work. Authorities in Saskatchewan previously launched inquiries into his operations after complaints were raised. At the same time, Goodenowe has taken legal action against critics and media organizations, alleging defamation.

Despite the growing criticism, Goodenowe continues to promote his work and future projects, including international expansion plans and new health programs. He maintains confidence in his research and believes his discoveries could change the future of medicine.

However, voices like Blaney’s highlight the risks involved and urge caution. He warned that new promises could attract more people into investing time, money, or trust without clear evidence of success. His statements reflect broader concerns about accountability and transparency in health-related claims.

The situation continues to draw attention as more questions arise about the balance between innovation and responsibility in the field of medical science.